Skip to main content
Metabolic Engineering Communications logoLink to Metabolic Engineering Communications
. 2021 Jul 17;13:e00177. doi: 10.1016/j.mec.2021.e00177

mfapy: An open-source Python package for 13C-based metabolic flux analysis

Fumio Matsuda 1,, Kousuke Maeda 1, Takeo Taniguchi 1, Yuya Kondo 1, Futa Yatabe 1, Nobuyuki Okahashi 1, Hiroshi Shimizu 1
PMCID: PMC8322459  PMID: 34354925

Abstract

13C-based metabolic flux analysis (13C-MFA) is an essential tool for estimating intracellular metabolic flux levels in metabolic engineering and biology. In 13C-MFA, a metabolic flux distribution that explains the observed isotope labeling data was computationally estimated using a non-linear optimization method. Herein, we report the development of mfapy, an open-source Python package developed for more flexibility and extensibility for 13C-MFA. mfapy compels users to write a customized Python code by describing each step in the data analysis procedures of the isotope labeling experiments. The flexibility and extensibility provided by mfapy can support trial-and-error performance in the routine estimation of metabolic flux distributions, experimental design by computer simulations of 13C-MFA experiments, and development of new data analysis techniques for stable isotope labeling experiments. mfapy is available to the public from the Github repository (https://github.com/fumiomatsuda/mfapy).

Keywords: 13C-based metabolic flux analysis, Experimental design, Non-linear optimization, Open-source software, Python package

Highlights

  • An open-source Python package, mfapy, is developed for 13C-MFA.

  • mfapy enables users to write Python codes for data analysis procedures of 13C-MFA.

  • mfapy has a flexibility and extensibility to support various data analysis procedures.

  • Computer simulations of 13C-MFA experiments is supported for experimental design.

1. Introduction

Measurement of intracellular metabolic flux is essential for metabolic engineering and biology (Antoniewicz, 2013, Antoniewicz, 2015; Wiechert, 2001; Wittmann, 2007; Zamboni et al., 2009). 13C-based metabolic flux analysis (13C-MFA) was developed to estimate metabolic flux levels in the central carbon metabolism of metabolically engineered microbial cells (Costenoble et al., 2007; Shirai et al., 2007; Wasylenko and Stephanopoulos, 2015). Recently, it has been applied to the quantitative analysis of cell metabolism in plants, mammalian cells, and cancers (Christen and Sauer, 2011; Gaglio et al., 2011; Haverkorn van Rijsewijk et al., 2011; Hiller and Metallo, 2013; Shimizu, 2004).

To perform 13C-MFA, cells are cultivated in a medium containing 13C-labeled carbon sources (Antoniewicz, 2018; Cheah et al., 2017; McAtee Pereira et al., 2018). Amino acids or intermediates are extracted and subjected to mass spectrometric analysis to measure the isotopic labeling enrichment or mass isotope distribution vector (MDV) of each metabolite. Additionally, specific rates for carbon source consumption and product excretion are determined from culture profile data. Because the MDV reflects intracellular metabolic flux levels, a metabolic flux distribution that effectively explains the observed data is computationally estimated using a non-linear optimization method (Matsuda et al., 2017). Several software packages can be used to perform the data analysis, such as 13CFLUX2 (Weitzel et al., 2013), C13 (Cvijovic et al., 2010), Metran (Yoo et al., 2008), INCA (Young, 2014), influx_s (Sokol et al., 2012), OpenFLUX2 (Shupletsov et al., 2014), WUflux (He et al., 2016), FluxPyt (Desai and Srivastava, 2018), and OpenMebius (Kajihata et al., 2014). These software packages contain functions required for the modern 13C-based MFA, including the rapid calculation of isotopic labeling enrichment using the elementary metabolite unit (EMU) framework (Antoniewicz et al., 2007b), determination of the confidence interval of the estimated flux level (Antoniewicz et al., 2006), parallel labeling experiments (Ahn and Antoniewicz, 2013; Crown et al., 2015; Leighty and Antoniewicz, 2013), and isotopically non-stationary MFA (INST-MFA) (Jazmin et al., 2014; Schaub et al., 2008; Young et al., 2008, 2011). Useful command-line-based or user-friendly graphic interfaces have been prepared for routine 13C-MFA. Moreover, several software packages have been distributed with open-source licenses (Desai and Srivastava, 2018; Kajihata et al., 2014; Sokol et al., 2012).

This article describes the development of mfapy, an open-source Python package for data processing of 13C-based metabolic flux analysis. Previously, we reported on OpenMebius for use in MATLAB (Kajihata et al., 2014). The advantages of MATLAB are its fast and reliable calculation environment with the manufacturer's support and many users, especially in chemical engineering field. However, Python was employed for the development of mfapy because Python is a freely available, popular programing language recently used for scientific purposes. A possible disadvantage is that Python is considered to be slow for operations on numerical data.

A novelty of mfapy is that it provides a set of functions required for a13C-based metabolic flux analysis as a Python package. In OpenMebius, a metabolic flux distribution can be estimated by six commands and Excel files, including model definition and experimental data. The command-line-based interface is useful for routine data processing of 13C-MFA. However, mfapy employs an object-oriented style interface that provides more than 70 methods to manipulate data and metabolic models for 13C-MFA. The flexibility and extensibility allow users to write or customize Python codes to describe various procedures for data analysis in isotope labeling experiments. For instance, computer estimation of the metabolic flux distribution by non-linear optimization requires trial and error to obtain the global optimum result without being trapped in local optima. Some flexibility is required in the routine data processing of 13C-MFA, such as selecting suitable non-linear optimization solvers to identify a plausible candidate for the global optimum. Moreover, a useful 13C-labeled carbon source must be selected to design a practical isotopic labeling experiment. Hence, a computer simulation of the isotopic labeling experiment was performed using artificial MDV data (Maeda et al., 2016). Furthermore, extensibility is required to develop advanced data analysis techniques, such as Monte Carlo-based algorithms, to generate a probability distribution of metabolic flux levels.

This study demonstrates that the flexibility and extensibility provided by mfapy enable us to write Python scripts for trial and error in routine 13C-MFA tasks, for computer simulation of 13C-MFA experiments to select suitable carbon sources, and for the development of new data analysis techniques. This article introduces various examples of Python scripts describing the procedure of 13C-MFA and other workflows. All Python scripts and related files mentioned in this study can be downloaded from the GitHub repository (https://github.com/fumiomatsuda/mfapy).

2. Materials and Methods

2.1. Implementation of mfapy and code availability

mfapy is implemented in Python 3 based on external packages, including NumPy (Harris et al., 2020), SciPy (Virtanen et al., 2020), nlopt (the non-linear optimization package by Steven G. Johnson, http://github.com/stevengj/nlopt), joblib (https://joblib.readthedocs.io/en/latest/), and mkl-service (Fig. 1a). We tested all mfapy functions using the 64-bit version of Anaconda3 (https://anaconda.com) for Windows. All scripts and example files of mfapy, detailed explanations of all functions, rules that describe the user-defined metabolic pathway, and the carbon transition network are available on the project home page (https://github.com/fumiomatsuda/mfapy). Documentation of each mfapy function is also available from GitHub (https://fumiomatsuda.github.io/mfapy-document/).

Fig. 1.

Fig. 1

Procedure for 13C-MFA by mfapy. (a) Screenshot of a python environment (PyScripter) running mfapy. (b) A typical scheme for estimating a best fitted metabolic flux distribution using the model definition, status, and MDV data files. Python codes for the parallel labeling experiment and the metabolic network of the toy model are shown in Supplementary Figs. 1 and 2.

The software comprises five modules: mfapy.mfapyio, mfapy.metabolicmodel, mfapy.mdv, mfapy.carbonsource, and mfapy.optimize. The mfapy.optimize submodule includes low-level functions for various optimization tasks and is not used by users directly. Fig. 1b shows a typical scheme for estimating the best-fitted metabolic flux distribution using mfapy. The mfapy package must be imported at the beginning of the Python 3 scripts (Fig. 1b, step 1). The corresponding Python code for the 13C-MFA of the toy model is shown in Supplementary Fig. 1.

2.2. Model construction

In 13C-MFA, a metabolic model M is constructed based on a metabolic pathway network and carbon transition network. M is a function for calculating the isotopic labeling enrichment or a mass isotope distribution vector (MDVsim) of metabolites from a specified vector of metabolic flux (v) and isotopic labeling patterns of carbon sources (xinp).

MDVjsim=M(v,xinp) (1)

Because the metabolic flux distribution at a metabolically steady state is determined, the vector of metabolic flux (v) follows the stoichiometric equation, Sv = 0, where S is the stoichiometric matrix produced from the stoichiometry of metabolic reactions. MDVjsim is calculated by the framework of EMUs (Antoniewicz et al., 2007b) using the carbon transition information of each metabolic reaction. In mfapy, the metabolic model M is implemented as a MetabolicModel class in the mfapy.metabolicmodel module. An instance of the MetabolicModel class can be generated from a model definition file describing the stoichiometry and carbon transition information of each metabolic reaction (Fig. 1b, step 2, Table 1). The number of carbons, symmetry, and other metabolite properties as well as reversible reactions and target fragments for measurements are also described in the model definition file (Table 1 and Supplementary Table 1).

Table 1.

Example of model definition file (extracted from Supplementary Table 1 or Example_1_toymodel_model.txt).

//Reactions
Id
For Stoichiometry Matrix
For Atom mapping
Atom mapping
Link to external ID
v1 AcCoA + OAC-- > Cit AcCoA + OAC-- > Cit AB + CDEF-- > FEDBAC (kegg:R00351)
v2 Cit-- > AKG + CO2ex Cit-- > AKG + CO2ex ABCDEF-- > ABCDE + F (kegg:R00709)
v3 AKG-- > Glu AKG-- > Glu ABCDE-- > ABCDE (kegg:R00243)
v4 AKG-- > Suc + CO2ex AKG-- > Suc + CO2ex ABCDE-- > BCDE + A (kegg:R01197)
v5 Suc-- > Fum Suc-- > Fum ABCD-- > ABCD (kegg:R02164)
v6 Fum-- > OAC Fum-- > OAC ABCD-- > ABCD (kegg:R01082)
v7 OAC-- > Fum OAC-- > Fum ABCD-- > ABCD (kegg:R01082)
v8 Asp-- > OAC Asp-- > OAC ABCD-- > ABCD (kegg:R00355)
v9
Glu-- > Gluex
nd
nd
(kegg:R00243)
//Metabolites
Name
Number of carbons
Symmetry
Carbon source
Excreted metabolite
CO2ex 1 no no excreted
AcCoA 2 no carbonsource no
OAC 4 no no no
Cit 6 no no no
AKG 5 no no no
Suc 4 symmetry no no
Fum 4 symmetry no no
Glu 5 no no no
Gluex 5 no no excreted
Asp 4 no carbonsource no

2.3. Addition of constraints

mfapy considers four types of metabolic reactions, including “free,” “fixed,” “fitting,” and “pseudo” types, to constrain v by observed rates of biomass synthesis, substrate consumption, and product excretion. The metabolic flux level of a “free” reaction is a free variable between the lower and upper boundaries. The metabolic flux level of a “fixed” reaction is constrained to a specified observed flux value. The metabolic flux level of a “fitting” reaction is a variable between the lower and upper boundaries, and its residue against a specified flux value is considered in the residual sum of squares (RSS) in the model fitting. The “pseudo”-type reactions are disregarded in constructing a stoichiometry matrix of its substrate (Supplementary Fig. 3) (Desai and Srivastava, 2018). These constraints for each reaction are described in “Example_1_toymodel_status.csv” (Table 2) and applied to the model (Fig. 1b, step 3).

Table 2.

Example of a status file (Example_1_toymodel_status.csv).

Class Id type Value1) Standard deviation2) Lower boundary Upper boundary
reaction v1 fixed 100 1 0 300
reaction v2 free 100 1 0 300
reaction v3 free 50 1 0 300
reaction v4 free 50 1 0 300
reaction v5 free 50 1 0 300
reaction v6 free 125 1 0 300
reaction v7 free 75 1 0 300
reaction v8 free 50 1 0 300
reaction v9 free 50 1 0 300
reversible FUM free 50 1 0 300

1) Metabolic flux level information was used for fixed and fitting types.

2) Standard deviation information was used for fitting type only.

2.4. Labeling patterns of carbon sources

mfapy comprises a CarbonSource class to handle the isotopic labeling information of carbon sources (xinp). An instance of the class is automatically generated from a MetabolicModel instance by the “generate_carbon_source_template” method. The isotope labeling patterns can be set using the “set_each_isotopomer” method (Fig. 1b, step 4).

2.5. Loading of observed MDV data

The isotopic labeling enrichment of metabolites is described by the MDV (Wittmann and Heinzle, 1999):

MDVj=m+0m+1m+nwithi=0nm+i=1 (2)

where MDVj is the vector of isotopic labeling enrichment of metabolite j;m+i indicates the relative abundance of a metabolite, in which i carbons are labeled with 13C. The mass spectrum data are rectified for the presence of naturally occurring isotopes using a correction matrix to obtain the MDVj of the carbon skeleton (van Winden et al., 2002). An observed MDV dataset described in “Example_1_MDV1.txt” yields an instance of the MdvData class (Table 3 and Fig. 1b, step 5).

Table 3.

Example of MDV file (Example_1_MDV1.txt).

Name Isotopomer Select MDV Standard deviation
GluMeas 0 1 0.012477 0.01
GluMeas 1 1 0.733379 0.01
GluMeas 2 1 0.254143 0.01
GluMeas 3 1 0.0 0.01
GluMeas 4 1 0.0 0.01
GluMeas 5 1 0.0 0.01

2.6. Metabolic flux estimation

A vector of metabolic flux v is fitted to the observed mass spectrum (MDˆVj) using a non-linear optimization method:

RSS(v)=j=1N([MDˆVjMDVjsim]TCMDˆVj1[MDˆVjMDVjsim])
vopt=argminvRSS(v)s.t.Sv=0 (3)

The optimized value vopt is the estimated metabolic flux distribution in the cells to minimize the covariance-weighted sum of squared difference. CMDˆVjis the covariance matrix with a measurement standard deviation located on the diagonal.

In mfapy, the estimation of vopt is executed by a three-step procedure using the methods of the MetabolicModel class. In step 6 in Fig. 1b, a pair of observed MDV datasets and the isotopic labeling information of carbon sources are registered as “a labeling experiment” using the set_experiment method. In step 7 in Fig. 1b, a random initial flux distribution is generated using the generate_initial_states method. In step 8 in Fig. 1b, the metabolic flux vector v is optimized using the fitting_flux method to minimize the covariance-weighted sum of squared difference (Eq. [3]). To solve the non-linear optimization problem, mfapy employs Scipy and nlopt packages supporting 13 global and local optimizers, such as sequential quadratic programming (SLSQP) and CRS2_LM (“controlled random search with local mutation”).

2.7. Determination of confidence intervals

The confidence intervals of the estimated fluxes are determined using the grid search method (Antoniewicz et al., 2006; Costenoble et al., 2007). Following the generation of a template dictionary (ci_enge) to describe the target reactions, the 95% confidence interval is determined using the search_ci method (Fig. 1b, step 9).

2.8. Generation of artificial MDV

An artificial observed MDV is used for computer simulation of the 13C-MFA experiment. For a specified metabolic flux vector, v, and carbon source (such as the cs prepared above), an MDVdata instance, including simulated MDV data, can be generated by the “generate_mdv” method of the MetabolicModel instance. The MDVdata instance comprises “add_gaussian_noise” and “set_std” to add Gaussian noise to the MDV data and set standard deviation levels for the MDV measurement. A Python code example for this task is as follows:

#Generation of artificial MDV
mdv = model.generate_mdv(v, cs)
mdv.add_gaussian_noise(0.01)
mdv.set_std(0.01)

2.9. Metropolis-Hastings algorithm

The Metropolis-Hastings algorithm is performed as follows:

  • (1)

    A seed metabolic flux distribution v is produced by minimizing the RSS(v) using the MetabolicModel.fitting_flux method, as described above.

  • (2)

    Based on the flux distribution at the jth step, v, a proposal flux distribution, v’, is generated by adding random values to the flux level of three randomly selected reactions. Proposal flux distributions are iteratively generated until a v’ within a feasible flux space is obtained using the MetabolicModel.add_perturbation method.

  • (3)

    If the acceptance probability p = P (RSS(v’))/P (RSS(v)) is larger than 1.0, then (v’) is accepted for the next step. P is the probability distribution of the χ2 distribution (the degree of freedom is the number of measurements). If p < 1.0, v’ is accepted with probability p. When v’ is rejected, v is used in the next step.

  • (4)

    The procedure is repeated 5,000,000 times to generate a Markov chain because at least 100,000–1,000,000 steps are required to obtain a stable estimate (Matsuda et al., 2020). The data of the initial 2,500,000 steps are discarded during the burn-in process.

  • (5)

    The remaining chain with 2,500,000 steps is used as the sample population of v, following a posterior distribution. From the population, 2500 data points are obtained by sampling every 1000 steps of the chain.

  • (6)

    The entire procedure is performed 20 times via parallel computing.

  • (7)

    A sample population of 50,000 data points (2500 with 20 replicates) is used for the following data analysis. The entire procedure is available in the MetabolicModel.posterior distribution method.

2.10. Test data

A toy model of the tricarboxylic acid (TCA) cycle was obtained from a previous study (Antoniewicz et al., 2007b). Two 13C-MFA datasets described in our previous study, including a metabolically engineered Escherichia coli strain producing isopropanol (Okahashi et al., 2017) and breast cancer cells (Araki et al., 2018), were used as examples.

3. Results

3.1. Test of mfapy: MDV calculation using an EMU algorithm

mfapy uses the framework of the EMU algorithm to determine a simulated MDV (MDVjsim) from vectors of the metabolic flux (v) and the isotopic labeling pattern of the carbon source (xinp) (Antoniewicz et al., 2007b). In the original article about the EMU algorithm, an example of MDV calculation based on a toy model of the TCA cycle, including nine reactions and 10 metabolites, was introduced (Supplementary Fig. 2) (Antoniewicz et al., 2007b). In this study, we prepared a model definition file of the toy model (Example_0_toymodel_model.txt, Supplementary Table 1) and a Python script describing a procedure to calculate the MDV of glutamate (Example_0_toymodel.py). In the procedure, following the construction of the metabolic model from the model definition file, the MDV of glutamate (MDVGlusim) was determined using Eq. (1) using v and xinp from the original literature (100% non-labeled Asp and [non-labeled AcCoA: [1–13C]Ac-CoA: [U–13C]Ac-CoA] = [50:25:25]). The obtained MDVGlusim was identical to the theoretical values shown in the original literature (Supplementary Table 2), indicating that the EMU algorithm was implemented exactly and performed as intended in mfapy.

3.2. Test of mfapy: 13C-MFA of metabolically engineered E. coli

In our previous study, 13C-MFA was conducted to estimate the metabolic flux distribution of the central carbon metabolism of a metabolically engineered E. coli strain to produce isopropanol using the authentic 13C-MFA software OpenMebius (Okahashi et al., 2017). The metabolically engineered strain (MSI002 strain) was cultured in an M9 medium containing 13C-labeled glucose (glucose : [1–13C]glucose : [U–13C]glucose = 2:70:28). Cells were collected in an exponential growth phase (OD600 ~1) to measure the MDV of proteinogenic amino acids by GC-MS. Furthermore, the specific rates for glucose consumption, and acetate, acetone, and isopropanol production were determined from the culture profile data. The metabolic flux distribution of central carbon metabolism was successfully estimated from the MDV of 23 fragments of proteinogenic amino acids and specific rate data using the metabolic model of E. coli, including 85 reactions. G-value parameters were included in each target fragment by applying a patch to the source code of OpenMebius to rectify the effects of inoculated unlabeled proteinogenic amino acids on the observed MDV (Antoniewicz et al., 2007a; Okahashi et al., 2017).

Here, the procedure for data processing in the previous 13C-MFA study was transported to a Python code using mfapy functions (“Example_2_1_Ecoli.py”). A metabolic model definition file (“Example_2_Ecoli_model.txt”) and status file (“Example_2_Ecoli_status.csv”) were prepared from the original data from the literature. To manage the G-value parameters, a specific reaction type, “pseudo,” can be used in mfapy (see Supplementary Fig. 3 for details). The metabolic flux vector v was optimized to minimize the difference between the observed and simulated MDVs (Eq. [3]). The metabolic flux vector v of the best-fitted optimization determined via mfapy was identical to that determined using OpenMebius in a previous study (Supplementary Fig. 4, Supplementary Table 3). This task required approximately 0.4 h when performed using AMD Ryzen 9 3900X (12 core, 3.8G Hz) processor.

3.3. Function of mfapy: availability of multiple solvers

mfapy employs Scipy and nlopt external packages to support 13 global and local non-linear optimization solvers. Various solvers with distinct algorithms have been developed owing to the compatibility between the algorithms and non-linear optimization problems. To investigate the compatibility with 13C-MFA, the performance of 13 solvers was compared by solving the E. coli example (Example_2_2_Ecoli_solver_comparison.py).

For example, following a generation of a population of 100 random initial metabolic flux vectors, each metabolic flux vector was optimized for 60 s using the SLSQP algorithm. The median RSS level among the 100 metabolic flux vectors was 20,896 (Fig. 2a). The procedure was repeated for the 13 solvers using an identical population of the initial metabolic flux vectors. Fig. 2a shows that, among the eight local optimization solvers, the best result was obtained for “LN_SBPLX (Subplex),” whose median RSS value was 1660. The second-best solver was “LN_BOBYQA” (bound optimization by quadratic approximation; median RSS value of 4400). For the cases of global solvers, the best result was obtained for “GN_CRS2_LM (controlled random search with local mutation)” with a median RSS value of 12,953.

Fig. 2.

Fig. 2

Performance comparison of 13 non-linear optimization solvers. Following the preparation of 100 initial metabolic flux vectors, each metabolic flux vector was optimized for 60 s using a non-linear optimization solver. Median RSSs of 100 metabolic flux vectors are shown in the figure. (a) Comparison using a13C-MFA dataset of E. coli (Okahashi et al., 2017). (b) Comparison using a13C-MFA dataset of cancer cells (Araki et al., 2018).

A similar comparison was performed using a dataset obtained from a previous 13C-MFA study of breast cancer (MCF-7) cells (Araki et al., 2018) (Example_3_MCF7.py). MCF-7 breast cancer cells were cultured in media containing non-labeled glucose and [U–13C]glutamine, as well as [1–13C]glucose and non-labeled glutamine, in parallel. Intracellular metabolites were extracted at 24 h and analyzed via mass spectrometry to obtain the MDV of 16 fragments of 7 metabolites. The specific rates for glucose, glutamine consumption, and lactate production were determined from the culture profile data. The MDV, specific rate data, and the metabolic model for MCF-7 including 85 reactions obtained in the previous study were used for the comparison of 13 optimization solvers in this study.

The result showed that “GN_CRS2_LM” yielded the best median RSS value of 44 among five global solvers, although performance of other global optimization solvers depended heavily on the dataset (Fig. 2b). Furthermore, the best and second-best local solvers were “LN_NELDERMEAD (the Nelder–Mead simplex algorithm)” and “SLSQP,” with median RSS values of 103 and 150, respectively. For local optimization, “LN_SBPLX (Subplex),” “LN_BOBYQA,” “LN_NELDERMEAD,” and “SLSQP” were typically better than the other solvers in the two examples. We empirically selected “GN_CRS2_LM” and “SLSQP” as the first option in a new 13C-MFA study, and tested other solvers because of the solver dependency on datasets.

3.4. Function of mfapy: parallel execution of optimization tasks for finding the global optimum

Non-linear optimization solvers often fail to reach the global optimum because they are trapped in a local optimum or their optimization progress is slow. To avoid local optima, mfapy can execute optimization trials from many random initial metabolic flux vectors in parallel processors using a task-parallel execution environment of the joblib module. In this study, global and local optima were investigated using the E. coli example above. The procedure for model fitting was changed by modifying the Python code (Example_2_3_Ecoli_local_optimum.py). An optimization trial comprised the global optimization by GN_CRS2_LM with 10,000 optimization steps, followed by a gradient-based local optimization (SLSQP). Optimization trials from 1000 random initial metabolic flux vectors were executed in parallel, while the optimization progression was monitored.

A comparison between the RSS and metabolic flux level of pyruvate dehydrogenase (PDH) showed that optimizations remained incomplete after the 10,000 steps of SLSQP (Fig. 3a). The RSS of 106 and 359 trials were below the threshold after 200,000 and 1,000,000 SLSQP steps, respectively (Fig. 3b and c). The metabolic flux level of PDH converged to a single value as optimization progressed (Fig. 3c).

Fig. 3.

Fig. 3

Investigation of global and local optima in 13C-MFA of metabolically engineered E. coli. Metabolic models and measurement data were obtained from a previous study (Okahashi et al., 2017). Model fitting was performed by the gradient-based local optimization (SLSQP). A total of 1000 optimization trials were executed in parallel. (a–f) Progression of optimization of 1000 trials. Metabolic flux levels of PDH (a–c) and G6PDH (d–f) reactions at the 10,000th (a and d), 200,000th (b and e), and 1,000,000th (c and f) steps are shown in figure. (g and h) Metabolic flux distribution of global (g) and local (h) optimum results. Blue numbers represent metabolic flux levels. Blue lines indicate significant carbon flow toward glycine and phenylalanine. White and black circles indicate 13C-labeling patterns of carbon source (glucose, Glc) and GAP and PYR produced by the ED pathway. All metabolic flux levels are normalized to that of the glucose uptake rate. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Furthermore, a comparison between the RSS and metabolic flux level of the reaction of glucose 6-phosphate dehydrogenase (G6PDH) revealed a global and local optimum below the RSS threshold. Although 339 trials reached the global optimum, 20 trials were trapped in the local minimum after 1,000,000 steps (Fig. 3d–f).

A metabolically engineered strain (MSI002 strain) was constructed in a previous study by removing the phosphoglucose isomerase (PGI) reaction and activation of the Entner–Doudoroff (ED) pathway (Okahashi et al., 2017). However, 13C-MFA was conducted using a metabolic network, including a reversible PGI reaction. Moreover, the reactions of fructose 1,6-bisphosphatase (FBPase; FBP→F6P) and PEP synthetase (Pps; pyruvate→PEP) were considered based on experimental validation (Okahashi et al., 2017). The metabolic flux vector of the global optimum result showed that the metabolic flux level of the PGI reaction was successfully determined to be zero (Fig. 3g, Supplementary Table 3). Glucose was catabolized via the ED pathway to produce glyceraldehyde 3-phosphate (GAP) and pyruvate (PYR). Subsequently, GAP was converted to PYR by the lower Embden–Meyerhof–Parnas (EMP) pathway (Fig. 3g).

In the local optimum, the GAP produced by the ED pathway was converted to glucose 6-phosphate (G6P) via the gluconeogenesis pathway and entered the ED pathway again, as shown in Fig. 3h. A comparison between the observed MDV and the simulated MDVs of the global and local optima suggested that the RSS of glycine-derived fragments in the local optimum was smaller than that of the global optimum (Supplementary Table 4). In contrast, the RSS of the m+3 signals of phenylalanine-related fragments significantly increased in the local optimum. This implies that, in the global optimum result, the [U–13C]GAP and non-labeled GAP produced via the ED pathway were primarily used for glycine and phenylalanine biosynthesis because of the high metabolic flux levels of the lower EMP pathway (Fig. 3g). In contrast, for the local optimum results (Fig. 3h), [U–13C]Pyr, [1–13C]Pyr and non-labeled Pyr produced via the ED pathway were used for the synthesis of glycine and phenylalanine. An optimization descent may be trapped in the local minimum when a metabolic flux vector v possesses the latter distribution during the optimization process. The results confirmed that the local optimum was caused by the characteristics of the metabolic network and the small experimental error in the observed MDV of glycine. Furthermore, the example showed that many optimization trials are required to obtain the global optimum.

3.5. Function of mfapy: generation of artificial observed MDV for simulating 13C-MFA experiments

In the 13C-MFA, 95% confidence intervals were determined for each metabolic reaction to evaluate the reliability of the flux estimation. To minimize the 95% confidence intervals, a suitable 13C-labeled carbon source should be used for labeling experiments (Crown and Antoniewicz, 2012). A computer simulation of a13C-MFA experiment is useful in the determination of suitable carbon sources (Maeda et al., 2016). mfapy includes required functions, such as the generation of an artificial observed MDV (see Materials and Methods).

Here, a computer simulation was performed to confirm the previous finding that a mixture of [U–13C]glucose and non-labeled glucose was better than 100% [1–13C]glucose as the carbon source to determine the flux in an anaplerotic reaction (Crown et al., 2015; Millard et al., 2014; Shupletsov et al., 2014) (“Example_4_Simulation.py”). For this purpose, an expanded toy model of the TCA cycle and the metabolic flux vector v shown in Fig. 4a were used (“Example_4_Simulation_model.txt”). Furthermore, it was assumed that the isotope labeling patterns of α-ketoglutarate (AKG), oxaloacetate (OAC), and phosphoenolpyruve (PEP) were observed via mass spectrometry.

Fig. 4.

Fig. 4

Computer simulation of 13C-MFA for the selection of an effective carbon source. (a) Expanded toy model of central carbon metabolism of E.coli. (b) Comparison of 95% confidence intervals of three anaplerotic reactions (v4, v5, and v6) and one non-anaplerotic reaction (v7) determined via simulation of 13C-MFA using distinct carbon sources. Red dotted lines represent metabolic flux levels of answers. [1–13C]glucose: 100% [1–13C]glucose, [U–13C]glucose: [U–13C]glucose and non-labeled glucose at 50:50 ratio, Mixture: [U–13C]glucose and [1–13C]glucose at 50:50 ratio, Parallel: parallel labeling experiment using 100% [1–13C]glucose and the mixture of [U–13C]glucose and non-labeled glucose at 50:50 ratio. (c) Comparison of 95% confidence intervals of v4 determined by simulation of 13C-MFA using distinct measured metabolites.

For the case of 13C-MFA using 100% [1–13C]glucose as the carbon source (denoted as 100% [1–13C]glucose), the simulated MDV of AKG, OAC, and PEP was calculated using Eq. (1). From the simulated MDV, an artificial observed MDV was generated by the addition of Gaussian noise (σ = 0.01; see Materials and Methods for the detailed procedure). Subsequently, a 13C-MFA was simulated by identifying an optimum metabolic flux vector using the artificial observed MDV data and determining the 95% confidence intervals of three anaplerotic reactions (v4, v5, and v6) and one non-anaplerotic reaction (v7). The procedure was repeated 100 times to yield a population of 95% confidence intervals, because the results of the 13C-MFA simulation depend on Gaussian noise used to create the artificial observed MDV. The median 95% confidence interval was used as a representative value.

Fig. 4b shows that the width of the 95% confidence interval of v4 (PEP carboxylase reaction) was 68 (range, 48–116). The 95% confidence interval was five times larger than that of v7 (pyruvate dehydrogenase reaction), with a 95% confidence interval of 15 (range, 98–113). Similar wide confidence intervals were observed for other anaplerotic reactions (v5 and v6). Moreover, an identical procedure was performed using another carbon source containing [U–13C]glucose and non-labeled glucose at a 50:50 ratio (denoted as 50% [U–13C]glucose). The width of the 95% confidence interval of reaction v4 was 36 (range, 50–86). The metabolic network (Fig. 4a) shows that reactions v4 and v5 form a reversible interconversion that mixes the 13C-labeling patterns of PEP and OAC. This means that an estimation of the interconversion level will be difficult when the overall percentage of 13C in PEP and OAC is low. Because the overall percentage of 13C in 100% [1–13C]glucose (17%) is lower than that of 50% [U–13C]glucose (50%), these results suggest that 100% [1–13C]glucose is an undesirable carbon source compared to 50% [U–13C]glucose for the analysis of the anaplerotic reactions.

To reduce the range of the confidence interval, a mixture of [1–13C]glucose:[U–13C]glucose at 50:50 is likely a better carbon source because of interactions between [1–13C]glucose and [U–13C]glucose (denoted as Mixture). Alternatively, it has been reported that the parallel execution of multiple labeling experiments, such as two labeling experiments using 100% [1–13C]glucose and 50% [U–13C]glucose, can improve the flux estimation performance (Parallel) (Ahn and Antoniewicz, 2013; Leighty and Antoniewicz, 2013; Maeda et al., 2016). The computer simulation of the Mixture and Parallel cases showed that the 95% confidence intervals determined by the Mixture were similar to that of 100% [1–13C]glucose, indicating that no specific interaction occurred in the mixing of the carbon source to decrease the intervals. In contrast, the results supported that the parallel labeling experiment was useful for improving the flux estimation because the 95% confidence intervals of all reactions were the narrowest among the four carbon sources.

Next, based on the experimental design, we determined the more important metabolite or mass isotopomer for estimating metabolic flux levels. As mentioned above, it was assumed that the isotope labeling patterns of AKG, OAC, and PEP were observed via mass spectrometry in the computer simulation of 13C-MFA. One approach to identify better target metabolites for measurement is to compare the simulated 95% confidence intervals using distinct sets of target metabolites. As previously stated, the 95% confidence interval of v4 was determined to be 36 (from 50 to 86) for the computer simulation of 13C-MFA using 50% [U–13C]glucose as the carbon source (Fig. 4b and c). Additional computer simulations showed that the 95% confidence intervals expanded to 62 (AKG and OAC), 129 (AKG and PEP), and 43 (OAC and PEP) when the isotope labeling patterns of the two metabolites were used for the 13C-MFA (Fig. 4c). The results showed that the MDV data of OAC were more important than those of other metabolites because the 95% confidence intervals expanded significantly when the MDV data of OAC were removed from the MDV dataset. These examples show that mfapy can describe various data analysis workflows for the computer simulation of 13C-based metabolic flux analysis.

3.6. Function of mfapy: computational basis for developing alternative methodologies

The flexibility and extensibility provided by mfapy can support the development of new data analysis techniques for stable isotope labeling experiments, such as a Bayesian approach (Heinonen et al., 2019; Kadirkamanathan et al., 2006). In this study, a Markov chain Monte Carlo (MCMC) algorithm was applied to select useful mass isotopomers for 13C-MFA. From a Bayesian perspective, we did not possess any information regarding the metabolic flux vector v or the metabolic flux levels of v before measuring the MDV of the target metabolites. After measuring the MDV of the target metabolites, we estimated the posterior distribution of v under the condition that the MDV data were observed. The probability distribution of flux vector v, P (RSS(v)), should follow a χ2 distribution (degree of freedom is the number of measurements) because the observed MDV data include an experimental error following the normal distribution. The Metropolis–Hastings method is an MCMC algorithm that generates a posterior distribution of v (see Materials and Methods for the detailed procedure).

An interesting application of this approach is the generation of a posterior distribution from a small number of MDV data points. A posterior distribution can be generated even if the number of data points is less than the degree of freedom of the metabolic model. Using the expanded toy model of the TCA cycle, we prepared a simulated MDV using the procedure described above without the addition of Gaussian noise. The relative intensity of the +3 isotopomer of the OAC was obtained from the simulated MDV. Using only one data point, a posterior distribution of v4 was successfully obtained using the Metropolis–Hastings method, as shown in Fig. 5a. The metabolic flux levels of the 2.5 and 97.5 percentile points of the posterior distribution were 55 and 161, respectively. In contrast, the same analysis using the +0 isotopomer of OAC yielded an extremely broad distribution (Fig. 5b). These results suggest that the observation of the +3 isotopomer of OAC was more critical than that of the +0 isotopomer of OAC for estimating the metabolic flux level of v4. Fig. 5c shows the metabolic flux levels of 2.5 and 97.5 percentile points of the posterior distributions determined for every isotopomer of OAC, AKG, and PEP. The comparison showed that the +1, +2, and +3 isotopomers of OAC were the most important measurement targets for estimating the metabolic flux level of v4, and that the result was identical to that of the 95% confidence interval-based method (Fig. 4c).

Fig. 5.

Fig. 5

A Bayesian approach to determine important metabolites or mass isotopomers for estimating metabolic flux levels. Computer simulations were performed using the expanded toy model for the case of 50% [U–13C]glucose as the carbon source. (a and b) Posterior distributions of metabolic flux level of v4 determined using Metropolis–Hastings method when +3 isotopomer (a) and +0 isotopomer (b) of OAC were used as the measured data. (c) Comparison of 95% intervals of posterior distributions when each isotopomer, i.e., OAC, AKG, and PEP, was used as the measured data. In all simulations, [U–13C]glucose and non-labeled glucose at a 50:50 ratio were used as carbon sources.

To implement the Metropolis–Hastings method, we first developed an mfapy-based Python code describing the procedure (“Example_5_1_MonteCalro.py”). Subsequently, the method to execute the entire Metropolis–Hastings algorism was newly added to a MetabolicModel class (“Example_5_2_MonteCalro.py”). A generation of one posterior distribution of v required approximately 0.5 h, whereas the determination of the 95% confidence intervals of 17 flux levels in the previous section required 4.3 h (using AMD Ryzen 9 3900 × 12 core processor). The demonstration suggested that extendability as an open-source Python package can provide a computational basis for developing alternative methodologies for 13C-labeling experiments.

3.7. Function of mfapy: isotopically non-stationary (INST)-MFA

mfapy supports INST-MFAs (Jazmin et al., 2014). The INST-MFA additionally needs pool size data of intracellular metabolites and time-course MDV data. The example python code, “Example_6_INSTMFA_toymodel.py,” describes a procedure for a computer simulation of INST-MFA using the toy model. The pool size levels of each metabolite can be considered as “free,” “fixed,” and “fitting” similar to the metabolite flux levels. By setting the time point information, the generate_mdv method can generate the MdvTimeCourseData class to deal with a time-course MDV dataset (detailed information is available from the mfapy documentation web page, https://fumiomatsuda.github.io/mfapy-document/).

In our previous study, INST-MFA was applied to Synechocystis sp. PCC 6803 GT strain under photoautotrophic conditions using NaH13CO3 as the carbon source (Nakajima et al., 2017). Using the time course MDV data for 15 fragments of 13 free metabolites, an optimal metabolic flux distribution and metabolite pool size, which passed the χ2 test with α = 0.05, were estimated using non-linear fitting of predicted and measured time courses of MDV in the previous study (Nakajima et al., 2017). However, the fitting took an enormous amount of time (approximately 1 week) because numerical integration is needed to calculate the simulated time-course MDV data during the non-linear fitting.

4. Discussion

The Python package mfapy was developed to provide a toolbox for 13C-MFA. mfapy compels users to write Python codes and has no user-friendly graphical interface. However, various functions, including the availability of multiple solvers (Fig. 2), parallel execution of the optimization task (Fig. 3), generation of artificially observed MDV for simulating 13C-MFA experiments (Fig. 4), the basis for developing alternative methodologies (Fig. 5), and INST-MFA can facilitate 13C-MFA studies.

The availability of multiple solvers and the parallel execution of optimization tasks of mfapy enabled trial and error to obtain the global optimum, which have contributed to the success of previous 13C-MFA studies of E. coli (Wada et al., 2017), yeast (Hayakawa et al., 2015), and cultured breast cancer cells (Araki et al., 2018; Okahashi et al., 2015, Okahashi et al., 2018). Moreover, a better design for various 13C-MFA experiments was obtained by computer simulation of the 13C-labeling experiment. For instance, a computer simulation using mfapy revealed that 100% [2–13C]ethanol was the best carbon source among [1–13C]ethanol and [U–13C]ethanol for the 13C-labeling experiment of ethanol-assimilating Saccharomyces cerevisiae (budding yeast) (Hayakawa et al., 2018).

Furthermore, the flexibility of mfapy provided a basis for new data analysis techniques, including a Monte Carlo-based data analysis method recently developed for the quantitative assessment of metabolic reprogramming (Matsuda et al., 2020) (Example_5_2_MonteCalro.py). Flux analysis or isotopomer analysis instead of 13C-MFA has been widely used to investigate metabolic redirection and reprogramming, such as in cancer and immune cells (Brekke et al., 2012; Dong et al., 2017; Fan et al., 2014; Faubert et al., 2017; Lewis et al., 2014; Liu et al., 2016; Lussey-Lepoutre et al., 2015). In many cases, the metabolic flux ratio between the two pathways has been estimated from the 13C-labeling patterns or MDV of a few metabolites. For such cases, a Monte Carlo-based approach would be useful because it can generate a probability distribution of the metabolic flux vector v using a small number of data points. The deliverables were newly implemented in the mfapy package in this study.

mfapy has been continuously developed to enrich functions, such as loading various model definition formats and data visualization (Beyss et al., 2019). New versions will be available to the public from the Github repository.

CRediT author statement

Fumio Matsuda: Methodology, Software, Investigation, Writing – original draft, Reviewing, and Editing, Kousuke Maeda: Software, and Investigation, Takeo Taniguchi: Software, and Investigation, Yuya Kondo: Software, and Investigation, Futa Yatabe: Software, and Investigation, Nobuyuki Okahashi:, Methodology, Software, Investigation, Reviewing, and Editing, and Hiroshi Shimizu: Conceptualization and Supervision.

Research data

The Python script and model definition file can be downloaded from our GitHub repository: https://github.com/fumiomatsuda/mfapy.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

We thank Dr. Yoshihiro Toya and all laboratory members for their assistance with software development. This work was supported in part by Grants-in-Aid for Scientific Research (grant number 17H06303).

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.mec.2021.e00177.

Contributor Information

Fumio Matsuda, Email: fmatsuda@ist.osaka-u.ac.jp.

Kousuke Maeda, Email: maeda-kousuke-mt@alumni.osaka-u.ac.jp.

Takeo Taniguchi, Email: takeo_taniguchi@ist.osaka-u.ac.jp.

Yuya Kondo, Email: kondo@ist.osaka-u.ac.jp.

Futa Yatabe, Email: futa_yatabe@ist.osaka-u.ac.jp.

Nobuyuki Okahashi, Email: n-okahashi@ist.osaka-u.ac.jp.

Hiroshi Shimizu, Email: shimizu@ist.osaka-u.ac.jp.

Appendix. List of abbreviations

MDV

mass isotope distribution vector

13C-MFA

13C-based metabolic flux analysis

INST-13C-MFA

isotopically nonstationary 13C-metabolic flux analysis

AKG

α-ketoglutarate

AcCoA

acetyl-CoA

Cit

citrate

F6P

fructose-6-phosphate

FBP

fructose-1,6-bisphosphate

FUM

fumarate

G6P

glucose-6-phosphate

GAP

glyceraldehyde-3-phosphate

Gly

glycine;

OAC

oxaloacetate

Phe

phenylalanine;

PEP

phosphoenolpyruvate

3 PG

3-phosphoglycerate

Pyr

pyruvate; SUC: succinate

Appendix A. Supplementary data

The following is the Supplementary data to this article:

Multimedia component 1
mmc1.pdf (248.2KB, pdf)

References

  1. Ahn W.S., Antoniewicz M.R. Parallel labeling experiments with [1,2-13C]glucose and [U-13C]glutamine provide new insights into CHO cell metabolism. Metab. Eng. 2013;15:34–47. doi: 10.1016/j.ymben.2012.10.001. [DOI] [PubMed] [Google Scholar]
  2. Antoniewicz M.R. Using multiple tracers for 13C metabolic flux analysis. Methods Mol. Biol. 2013;985:353–365. doi: 10.1007/978-1-62703-299-5_17. [DOI] [PubMed] [Google Scholar]
  3. Antoniewicz M.R. Methods and advances in metabolic flux analysis: a mini-review. J. Ind. Microbiol. Biotechnol. 2015;42:317–325. doi: 10.1007/s10295-015-1585-x. [DOI] [PubMed] [Google Scholar]
  4. Antoniewicz M.R. A guide to 13C metabolic flux analysis for the cancer biologist. Exp. Mol. Med. 2018;50:19. doi: 10.1038/s12276-018-0060-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Antoniewicz M.R., Kelleher J.K., Stephanopoulos G. Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements. Metab. Eng. 2006;8:324–337. doi: 10.1016/j.ymben.2006.01.004. [DOI] [PubMed] [Google Scholar]
  6. Antoniewicz M.R., Kelleher J.K., Stephanopoulos G. Accurate assessment of amino acid mass isotopomer distributions for metabolic flux analysis. Anal. Chem. 2007;79:7554–7559. doi: 10.1021/ac0708893. [DOI] [PubMed] [Google Scholar]
  7. Antoniewicz M.R., Kelleher J.K., Stephanopoulos G. Elementary metabolite units (EMU): a novel framework for modeling isotopic distributions. Metab. Eng. 2007;9:68–86. doi: 10.1016/j.ymben.2006.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Araki C., Okahashi N., Maeda K., Shimizu H., Matsuda F. Mass spectrometry-based method to study inhibitor-induced metabolic redirection in the central metabolism of cancer cells. Mass Spectrom. 2018;7:A0067. doi: 10.5702/massspectrometry.A0067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Beyss M., Azzouzi S., Weitzel M., Wiechert W., Noh K. The design of FluxML: a universal modeling language for 13C metabolic flux analysis. Front. Microbiol. 2019;10:1022. doi: 10.3389/fmicb.2019.01022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brekke E.M., Walls A.B., Schousboe A., Waagepetersen H.S., Sonnewald U. Quantitative importance of the pentose phosphate pathway determined by incorporation of 13C from [2-13C]- and [3-13C]glucose into TCA cycle intermediates and neurotransmitter amino acids in functionally intact neurons. J. Cerebr. Blood Flow Metabol. 2012;32:1788–1799. doi: 10.1038/jcbfm.2012.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cheah Y.E., Hasenour C.M., Young J.D. 13C Flux analysis in biotechnology and medicine. Syst. Biol. 2017;6:25–70. [Google Scholar]
  12. Christen S., Sauer U. Intracellular characterization of aerobic glucose metabolism in seven yeast species by 13C flux analysis and metabolomics. FEMS Yeast Res. 2011;11:263–272. doi: 10.1111/j.1567-1364.2010.00713.x. [DOI] [PubMed] [Google Scholar]
  13. Costenoble R., Muller D., Barl T., van Gulik W.M., van Winden W.A., Reuss M., Heijnen J.J. 13C-Labeled metabolic flux analysis of a fed-batch culture of elutriated Saccharomyces cerevisiae. FEMS Yeast Res. 2007;7:511–526. doi: 10.1111/j.1567-1364.2006.00199.x. [DOI] [PubMed] [Google Scholar]
  14. Crown S.B., Antoniewicz M.R. Selection of tracers for 13C-metabolic flux analysis using elementary metabolite units (EMU) basis vector methodology. Metab. Eng. 2012;14:150–161. doi: 10.1016/j.ymben.2011.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Crown S.B., Long C.P., Antoniewicz M.R. Integrated 13C-metabolic flux analysis of 14 parallel labeling experiments in Escherichia coli. Metab. Eng. 2015;28:151–158. doi: 10.1016/j.ymben.2015.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cvijovic M., Olivares-Hernandez R., Agren R., Dahr N., Vongsangnak W., Nookaew I., Patil K.R., Nielsen J. BioMet Toolbox: genome-wide analysis of metabolism. Nucleic Acids Res. 2010;38:W144–W149. doi: 10.1093/nar/gkq404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Desai T.S., Srivastava S. FluxPyt: a Python-based free and open-source software for (13)C-metabolic flux analyses. PeerJ. 2018;6 doi: 10.7717/peerj.4716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dong W., Keibler M.A., Stephanopoulos G. Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis. Metab. Eng. 2017;43:113–124. doi: 10.1016/j.ymben.2017.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fan J., Ye J., Kamphorst J.J., Shlomi T., Thompson C.B., Rabinowitz J.D. Quantitative flux analysis reveals folate-dependent NADPH production. Nature. 2014;510:298–302. doi: 10.1038/nature13236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Faubert B., Li K.Y., Cai L., Hensley C.T., Kim J., Zacharias L.G., Yang C., Do Q.N., Doucette S., Burguete D., Li H., Huet G., Yuan Q., Wigal T., Butt Y., Ni M., Torrealba J., Oliver D., Lenkinski R.E., Malloy C.R., Wachsmann J.W., Young J.D., Kernstine K., DeBerardinis R.J. Lactate metabolism in human lung tumors. Cell. 2017;171:358–371 e9. doi: 10.1016/j.cell.2017.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gaglio D., Metallo C.M., Gameiro P.A., Hiller K., Danna L.S., Balestrieri C., Alberghina L., Stephanopoulos G., Chiaradonna F. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol. Syst. Biol. 2011;7:523. doi: 10.1038/msb.2011.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Harris C.R., Millman K.J., van der Walt S.J., Gommers R., Virtanen P., Cournapeau D., Wieser E., Taylor J., Berg S., Smith N.J., Kern R., Picus M., Hoyer S., van Kerkwijk M.H., Brett M., Haldane A., Del Rio J.F., Wiebe M., Peterson P., Gerard-Marchant P., Sheppard K., Reddy T., Weckesser W., Abbasi H., Gohlke C., Oliphant T.E. Array programming with NumPy. Nature. 2020;585:357–362. doi: 10.1038/s41586-020-2649-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Haverkorn van Rijsewijk B.R., Nanchen A., Nallet S., Kleijn R.J., Sauer U. Large-scale 13C-flux analysis reveals distinct transcriptional control of respiratory and fermentative metabolism in Escherichia coli. Mol. Syst. Biol. 2011;7:477. doi: 10.1038/msb.2011.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hayakawa K., Kajihata S., Matsuda F., Shimizu H. 13C-metabolic flux analysis in S-adenosyl-L-methionine production by Saccharomyces cerevisiae. J. Biosci. Bioeng. 2015;120:532–538. doi: 10.1016/j.jbiosc.2015.03.010. [DOI] [PubMed] [Google Scholar]
  25. Hayakawa K., Matsuda F., Shimizu H. 13C-metabolic flux analysis of ethanol-assimilating Saccharomyces cerevisiae for S-adenosyl-L-methionine production. Microb. Cell Factories. 2018;17:82. doi: 10.1186/s12934-018-0935-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. He L., Wu S.G., Zhang M., Chen Y., Tang Y.J. WUFlux: an open-source platform for (13)C metabolic flux analysis of bacterial metabolism. BMC Bioinf. 2016;17:444. doi: 10.1186/s12859-016-1314-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Heinonen M., Osmala M., Mannerstrom H., Wallenius J., Kaski S., Rousu J., Lahdesmaki H. Bayesian metabolic flux analysis reveals intracellular flux couplings. Bioinformatics. 2019;35:i548–i557. doi: 10.1093/bioinformatics/btz315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hiller K., Metallo C.M. Profiling metabolic networks to study cancer metabolism. Curr. Opin. Biotechnol. 2013;24:60–68. doi: 10.1016/j.copbio.2012.11.001. [DOI] [PubMed] [Google Scholar]
  29. Jazmin L.J., O'Grady J.P., Ma F., Allen D.K., Morgan J.A., Young J.D. Isotopically nonstationary MFA (INST-MFA) of autotrophic metabolism. Methods Mol. Biol. 2014;1090:181–210. doi: 10.1007/978-1-62703-688-7_12. [DOI] [PubMed] [Google Scholar]
  30. Kadirkamanathan V., Yang J., Billings S.A., Wright P.C. Markov chain Monte Carlo algorithm based metabolic flux distribution analysis on Corynebacterium glutamicum. Bioinformatics. 2006;22:2681–2687. doi: 10.1093/bioinformatics/btl445. [DOI] [PubMed] [Google Scholar]
  31. Kajihata S., Furusawa C., Matsuda F., Shimizu H. OpenMebius: an open source software for isotopically nonstationary 13C-based metabolic flux analysis. BioMed Res. Int. 2014;2014:627014. doi: 10.1155/2014/627014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Leighty R.W., Antoniewicz M.R. COMPLETE-MFA: complementary parallel labeling experiments technique for metabolic flux analysis. Metab. Eng. 2013;20:49–55. doi: 10.1016/j.ymben.2013.08.006. [DOI] [PubMed] [Google Scholar]
  33. Lewis C.A., Parker S.J., Fiske B.P., McCloskey D., Gui D.Y., Green C.R., Vokes N.I., Feist A.M., Vander Heiden M.G., Metallo C.M. Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell. 2014;55:253–263. doi: 10.1016/j.molcel.2014.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Liu L., Shah S., Fan J., Park J.O., Wellen K.E., Rabinowitz J.D. Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage. Nat. Chem. Biol. 2016;12:345–352. doi: 10.1038/nchembio.2047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lussey-Lepoutre C., Hollinshead K.E., Ludwig C., Menara M., Morin A., Castro-Vega L.J., Parker S.J., Janin M., Martinelli C., Ottolenghi C., Metallo C., Gimenez-Roqueplo A.P., Favier J., Tennant D.A. Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism. Nat. Commun. 2015;6:8784. doi: 10.1038/ncomms9784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Maeda K., Okahashi N., Toya Y., Matsuda F., Shimizu H. Investigation of useful carbon tracers for 13C-metabolic flux analysis of Escherichia coli by considering five experimentally determined flux distributions. Metab Eng Comm. 2016;3:187–195. doi: 10.1016/j.meteno.2016.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Matsuda F., Maeda K., Okahashi N. Computational data mining method for isotopomer analysis in the quantitative assessment of metabolic reprogramming. Sci. Rep. 2020;10:286. doi: 10.1038/s41598-019-57146-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Matsuda F., Toya Y., Shimizu H. Learning from quantitative data to understand central carbon metabolism. Biotechnol. Adv. 2017;35:971–980. doi: 10.1016/j.biotechadv.2017.09.006. [DOI] [PubMed] [Google Scholar]
  39. McAtee Pereira A.G., Walther J.L., Hollenbach M., Young J.D. 13C Flux analysis reveals that rebalancing medium amino acid composition can reduce ammonia production while preserving central carbon metabolism of CHO cell cultures. Biotechnol. J. 2018;13 doi: 10.1002/biot.201700518. [DOI] [PubMed] [Google Scholar]
  40. Millard P., Sokol S., Letisse F., Portais J.C. IsoDesign: a software for optimizing the design of 13C-metabolic flux analysis experiments. Biotechnol. Bioeng. 2014;111:202–208. doi: 10.1002/bit.24997. [DOI] [PubMed] [Google Scholar]
  41. Nakajima T., Yoshikawa K., Toya Y., Matsuda F., Shimizu H. Metabolic flux analysis of Synechocystis sp. PCC 6803 ΔnrtABCD mutant reveals a mechanism for metabolic adaptation to nitrogen-limited conditions. Plant Cell Physiol. 2017;58:537–545. doi: 10.1093/pcp/pcw233. [DOI] [PubMed] [Google Scholar]
  42. Okahashi N., Kohno S., Kitajima S., Matsuda F., Takahashi C., Shimizu H. Metabolic characterization of cultured mammalian cells by mass balance analysis, tracer labeling experiments and computer-aided simulations. J. Biosci. Bioeng. 2015;120:725–731. doi: 10.1016/j.jbiosc.2015.04.003. [DOI] [PubMed] [Google Scholar]
  43. Okahashi N., Maeda K., Kawana S., Iida J., Shimizu H., Matsuda F. Sugar phosphate analysis with baseline separation and soft ionization by gas chromatography-negative chemical ionization-mass spectrometry improves flux estimation of bidirectional reactions in cancer cells. Metab. Eng. 2018;51:43–49. doi: 10.1016/j.ymben.2018.08.011. [DOI] [PubMed] [Google Scholar]
  44. Okahashi N., Matsuda F., Yoshikawa K., Shirai T., Matsumoto Y., Wada M., Shimizu H. Metabolic engineering of isopropyl alcohol-producing Escherichia coli strains with 13C-metabolic flux analysis. Biotechnol. Bioeng. 2017;114:2782–2793. doi: 10.1002/bit.26390. [DOI] [PubMed] [Google Scholar]
  45. Schaub J., Mauch K., Reuss M. Metabolic flux analysis in Escherichia coli by integrating isotopic dynamic and isotopic stationary 13C labeling data. Biotechnol. Bioeng. 2008;99:1170–1185. doi: 10.1002/bit.21675. [DOI] [PubMed] [Google Scholar]
  46. Shimizu K. Metabolic flux analysis based on 13C-labeling experiments and integration of the information with gene and protein expression patterns. Adv. Biochem. Eng. Biotechnol. 2004;91:1–49. doi: 10.1007/b94204. [DOI] [PubMed] [Google Scholar]
  47. Shirai T., Fujimura K., Furusawa C., Nagahisa K., Shioya S., Shimizu H. Study on roles of anaplerotic pathways in glutamate overproduction of Corynebacterium glutamicum by metabolic flux analysis. Microb. Cell Factories. 2007;6:19. doi: 10.1186/1475-2859-6-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Shupletsov M.S., Golubeva L.I., Rubina S.S., Podvyaznikov D.A., Iwatani S., Mashko S.V. OpenFLUX2: 13C-MFA modeling software package adjusted for the comprehensive analysis of single and parallel labeling experiments. Microb. Cell Factories. 2014;13:152. doi: 10.1186/s12934-014-0152-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sokol S., Millard P., Portais J.C. influx_s: increasing numerical stability and precision for metabolic flux analysis in isotope labelling experiments. Bioinformatics. 2012;28:687–693. doi: 10.1093/bioinformatics/btr716. [DOI] [PubMed] [Google Scholar]
  50. van Winden W.A., Wittmann C., Heinzle E., Heijnen J.J. Correcting mass isotopomer distributions for naturally occurring isotopes. Biotechnol. Bioeng. 2002;80:477–479. doi: 10.1002/bit.10393. [DOI] [PubMed] [Google Scholar]
  51. Virtanen P., Gommers R., Oliphant T.E., Haberland M., Reddy T., Cournapeau D., Burovski E., Peterson P., Weckesser W., Bright J., van der Walt S.J., Brett M., Wilson J., Millman K.J., Mayorov N., Nelson A.R.J., Jones E., Kern R., Larson E., Carey C.J., Polat I., Feng Y., Moore E.W., VanderPlas J., Laxalde D., Perktold J., Cimrman R., Henriksen I., Quintero E.A., Harris C.R., Archibald A.M., Ribeiro A.H., Pedregosa F., van Mulbregt P., SciPy C. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods. 2020;17:261–272. doi: 10.1038/s41592-019-0686-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wada K., Toya Y., Banno S., Yoshikawa K., Matsuda F., Shimizu H. 13C-metabolic flux analysis for mevalonate-producing strain of Escherichia coli. J. Biosci. Bioeng. 2017;123:177–182. doi: 10.1016/j.jbiosc.2016.08.001. [DOI] [PubMed] [Google Scholar]
  53. Wasylenko T.M., Stephanopoulos G. Metabolomic and 13C-metabolic flux analysis of a xylose-consuming Saccharomyces cerevisiae strain expressing xylose isomerase. Biotechnol. Bioeng. 2015;112:470–483. doi: 10.1002/bit.25447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Weitzel M., Noh K., Dalman T., Niedenfuhr S., Stute B., Wiechert W. 13CFLUX2--high-performance software suite for 13C-metabolic flux analysis. Bioinformatics. 2013;29:143–145. doi: 10.1093/bioinformatics/bts646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wiechert W. 13C metabolic flux analysis. Metab. Eng. 2001;3:195–206. doi: 10.1006/mben.2001.0187. [DOI] [PubMed] [Google Scholar]
  56. Wittmann C. Fluxome analysis using GC-MS. Microb. Cell Factories. 2007;6:6. doi: 10.1186/1475-2859-6-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wittmann C., Heinzle E. Mass spectrometry for metabolic flux analysis. Biotechnology and Bioenginnering. 1999;62:739–750. doi: 10.1002/(sici)1097-0290(19990320)62:6<739::aid-bit13>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  58. Yoo H., Antoniewicz M.R., Stephanopoulos G., Kelleher J.K. Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line. J. Biol. Chem. 2008;283:20621–20627. doi: 10.1074/jbc.M706494200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Young J.D. INCA: a computational platform for isotopically non-stationary metabolic flux analysis. Bioinformatics. 2014;30:1333–1335. doi: 10.1093/bioinformatics/btu015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Young J.D., Shastri A.A., Stephanopoulos G., Morgan J.A. Mapping photoautotrophic metabolism with isotopically nonstationary 13C flux analysis. Metab. Eng. 2011;13:656–665. doi: 10.1016/j.ymben.2011.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Young J.D., Walther J.L., Antoniewicz M.R., Yoo H., Stephanopoulos G. An elementary metabolite unit (EMU) based method of isotopically nonstationary flux analysis. Biotechnol. Bioeng. 2008;99:686–699. doi: 10.1002/bit.21632. [DOI] [PubMed] [Google Scholar]
  62. Zamboni N., Fendt S.M., Ruhl M., Sauer U. 13C-based metabolic flux analysis. Nat. Protoc. 2009;4:878–892. doi: 10.1038/nprot.2009.58. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.pdf (248.2KB, pdf)

Articles from Metabolic Engineering Communications are provided here courtesy of Elsevier

RESOURCES